On June 9, 2025, Ernexa Therapeutics Inc. completed a second closing of a private placement, issuing 47,717,087 shares and raising approximately $6.0 million. This follows prior funds raised on April 2, 2025, totaling about $7.0 million from a sale of common stock and warrants, helping the company meet Nasdaq listing compliance with over $2.5 million in stockholders' equity.